Products For Cystic Fibrosis, VWD & Schizophrenia Nearing End Of EU Review

 
• By Ian Schofield

The European Medicines Agency's CHMP is expected this week to adopt Lists of Outstanding Issues on products for von Willebrand disease, cystic fibrosis and schizophrenia.

Question mark
The CHMP has final questions for manufacturers of three new drugs

More from Europe

More from Geography